Par Drugs and Chemicals Limited(IN:PAR)
₹119.00+0.66 (+0.56%)
IN:PAR
Par Drugs and Chemicals Limited stock forecast
₹119.00
At close:+0.66 (+0.56%)
Want to see IN:PAR full AI Analyst Report?
Par Drugs and Chemicals Limited (PAR) Stock Forecast & Price Target
1 Followers
PAR Analyst Ratings
Currently, no data available
PAR Stock 12 Month Forecast
There Are No Analyst Ratings for PAR In The Last 3 Months.
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | ₹122→₹135 | buy | 13.45%Upside | Reiterated | 10/30/26 | ||
| Google General IN | TipRanks - Google | ₹121→₹133 | buy | 11.76%Upside | Reiterated | 10/30/26 | ||
| Anthropic General IN | TipRanks - Anthropic | ₹118→₹130 | hold | 9.24%Upside | Downgraded | 10/30/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | ₹122→₹134 | buy | 12.61%Upside | Reiterated | 10/30/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | ₹119→₹132 | hold | 10.92%Upside | Downgraded | 10/30/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | ₹123→₹136 | buy | 14.29%Upside | Reiterated | 10/30/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| PerPlexity - SonarReasoningProTipRanks - PerPlexity | BuyReiterated₹122→₹135 | 10/30/26 | 13.45%Upside | ||
| Google General INTipRanks - Google | BuyReiterated₹121→₹133 | 10/30/26 | 11.76%Upside | ||
| Anthropic General INTipRanks - Anthropic | HoldDowngraded₹118→₹130 | 10/30/26 | 9.24%Upside | ||
| OpenAI - Gpt-5.6SolTipRanks - OpenAI | BuyReiterated₹122→₹134 | 10/30/26 | 12.61%Upside | ||
| DeepSeek - V4ProTipRanks - DeepSeek | HoldDowngraded₹119→₹132 | 10/30/26 | 10.92%Upside | ||
| xAI - Grok-4.3TipRanks - xAI | BuyReiterated₹123→₹136 | 10/30/26 | 14.29%Upside |
Stocks with the Highest Top Analyst Consensus in the General Sector
PAR Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, PAR has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PAR average Analyst price target in the past 3 months is ―.
PAR Financial Forecast
Consensus₹2.14
PAR Earnings Forecast
Next quarter’s earnings estimate for PAR is INR 2.14 with a range of ― to ―. The previous quarter’s EPS was INR 2.14. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
Consensus₹274M
PAR Sales Forecast
Next quarter’s sales forecast for PAR is INR 274.32M with a range of ― to ―. The previous quarter’s sales results were INR 274.32M. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.
PAR Stock Forecast FAQ
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Par Drugs and Chemicals Limited?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Par Drugs and Chemicals Limited?
To buy shares of IN:PAR, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
